Fabior

Active Ingredient(s): Tazarotene
FDA Approved: * May 11, 2012
Pharm Company: * STIEFEL LABS INC
Category: Skin Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Fabior Overview

Tazarotene (marketed as Tazorac, Avage, Zorac, and Fabior) is a third-generation prescription topical retinoid sold as a cream, gel, or foam. Tazarotene is a member of the acetylenic class of retinoids. This medication is approved for treatment of psoriasis, acne, and sun damaged skin (photodamage). It is commonly sold in two concentrations: 0.05% and 0.1%. Contents 1 Mechanism of action 2 Side effects 3 Uses 4 Synthesis 5 Notes Mechanism of action Tazarotene is a retinoid prodrug w...

Read more Fabior Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tazarotene

Recent Fabior Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Tazarotene
  • Aerosol, Foam: 0.1%
  • Cream: 0.05%, 0.1%, 0.10%
  • Foam: 0.1%
  • Gel: 0.05%, 0.1%, 0.10%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Fabior: (2 results)

Sorted by National Drug Code
  • 0145-0020 Fabior 1 mg/g Topical Aerosol, Foam by Stiefel Laboratories, Inc.
  • 51862-295 Fabior 1 mg/g Topical Aerosol, Foam by Mayne Pharma LLC

Other drugs which contain Tazarotene or a similar ingredient: (2 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 24 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA